Enzymatic activity assays revealed that Acer3 deficiency significantly decreased the serum levels of ALT and AST in NASH mice (Fig. 2k), indicating that loss of Acer3 indeed attenuates hepatocellular injury in NASH mice. This evidence concerns the gene ACER3 and metabolic dysfunction-associated steatohepatitis.